CENPB: A Promising Drug Target and Potential Biomarker for Major Centromere Autoantigen B

Target Name: CENPB

NCBI ID: G1059

CENPB

CENPB: A Promising Drug Target and Potential Biomarker for Major Centromere Autoantigen B

Major centromere autoantigen B (CENPB) is a protein that is expressed in most tissues and is involved in the regulation of microtubule dynamics and cytoskeleton organization. It has been identified as a potential drug target and biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. In this article, we will discuss the biology of CENPB, its potential drug targeting, and its potential as a biomarker for disease.

Biochemistry and localization

CENPB is a 21-kDa protein that is expressed in most tissues, including muscle, nerve, heart, and brain. It is predominantly localized to the centromere region of chromosomes, where it plays a critical role in regulating microtubule dynamics and cytoskeleton organization. CENPB is composed of a unique transmembrane domain, a cytoplasmic domain, and an N-terminus that contains a GFP-like gene.

Function and regulation

CENPB is involved in the regulation of microtubule dynamics and cytoskeleton organization, which are critical for cell signaling, division, and transport of organelles and vesicles within the cell. It does this by playing a role in the stability and dynamics of microtubules, which are dynamic structures composed of microtubule protein subunits that can interact with each other and with other cellular components to regulate cell signaling and behavior.

CENPB is also involved in the regulation of cytoskeleton organization, which is critical for cell stability and mechanical forces that maintain cell shape and integrity. It does this by playing a role in the organization and dynamics of the cytoskeleton, as well as in the regulation of actin filaments and microtubules.

Drug targeting and biomarker potential

CENPB has been identified as a potential drug target for several diseases due to its involvement in the regulation of microtubule dynamics and cytoskeleton organization. One of the main reasons for its potential as a drug target is its high expression level in various tissues, which suggests that it is not well-abundated and could be a good target for small molecule inhibitors.

In addition, CENPB has been shown to play a role in the regulation of cell signaling and has been implicated in several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its involvement in these diseases suggests that it may be a useful biomarker for identifying patients at risk for these diseases and for monitoring the effectiveness of potential therapies.

Furthermore, CENPB has been shown to interact with several other proteins, including the protein known as p53, which is a critical regulator of cell growth and apoptosis. This suggests that CENPB may be a useful target for small molecule inhibitors that target p53 and that are being developed for the treatment of p53-related diseases.

Conclusion

In conclusion, CENPB is a protein that is involved in the regulation of microtubule dynamics and cytoskeleton organization, and has been identified as a potential drug target for several diseases. Its high expression level in various tissues and its involvement in the regulation of cell signaling make it an attractive target for small molecule inhibitors. Its potential as a biomarker for disease makes it an important area of research for the development of new therapies for a variety of diseases.

Protein Name: Centromere Protein B

Functions: Interacts with centromeric heterochromatin in chromosomes and binds to a specific 17 bp subset of alphoid satellite DNA, called the CENP-B box (PubMed:11726497). May organize arrays of centromere satellite DNA into a higher-order structure which then directs centromere formation and kinetochore assembly in mammalian chromosomes (Probable)

The "CENPB Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CENPB comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets